Myriad Genetics | MYGN - Cash And Equivalent

Myriad Genetics reported $3.3M in Cash and Equivalent for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Cash And Equivalent Change
Accelerate Diagnostics AXDX:US USD 38.99M 34.41M
Agilent A:US USD 1.25B 197M
Becton, Dickinson and BDX:US USD 612M 394M
Bio Rad Laboratories BIO:US USD 434.22M 83.73M
Bruker BRKR:US USD 645.5M 19.3M
Danaher DHR:US USD 6B 845M
Exact Sciences EXAS:US USD 64.32M 2.99M
Fluidigm FLDM:US USD 81.31M 21.11M
Hologic HOLX:US USD 2.44B 101.8M
Illumina ILMN:US USD 2.01B 1.01B
Mettler Toledo International MTD:US USD 95.97M 26.17M
Myriad Genetics MYGN:US USD 3.3M 49.6M
Nanostring Technologies NSTG:US USD 112.25M 4.82M
Orasure Technologies OSUR:US USD 83.98M 8.78M
Pacific Biosciences Of California PACB:US USD 325.09M 20.66M
Perkinelmer PKI:US USD 454.36M 53.62M
Quest Diagnostics DGX:US USD 315M 385M
Quidel QDEL:US USD 292.9M 80.7M
Repligen RGEN:US USD 523.46M 49.9M
Thermo Fisher Scientific TMO:US USD 8.52B 5.6B
Veracyte VCYT:US USD 154.25M 15.86M
Waters WAT:US USD 481.39M 37.75M